173 related articles for article (PubMed ID: 22877565)
1. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
2. Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M.
Wolfrum C; Howell JJ; Ndungo E; Stoffel M
J Biol Chem; 2008 Jun; 283(24):16940-9. PubMed ID: 18381283
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
4. Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXRα expression in HepG2 cells.
Zhao JY; Hu YW; Li SF; Hu YR; Ma X; Wu SG; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
Lipids Health Dis; 2014 Mar; 13():50. PubMed ID: 24642298
[TBL] [Abstract][Full Text] [Related]
5. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
[TBL] [Abstract][Full Text] [Related]
6. Propofol Attenuates Lipopolysaccharide-Induced Monocyte Chemoattractant Protein-1 Production Through Enhancing apoM and foxa2 Expression in HepG2 Cells.
Ma X; Zhao JY; Zhao ZL; Ye J; Li SF; Fang HH; Gu MN; Hu YW; Qin ZS
Inflammation; 2015; 38(3):1329-36. PubMed ID: 25586482
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
[TBL] [Abstract][Full Text] [Related]
8. Increased apolipoprotein M induced by lack of scavenger receptor BI is not activated via HDL-mediated cholesterol uptake in hepatocytes.
Feng YH; Zheng L; Wei J; Yu MM; Zhang J; Luo GH; Xu N
Lipids Health Dis; 2018 Aug; 17(1):200. PubMed ID: 30144814
[TBL] [Abstract][Full Text] [Related]
9. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1α-dependent manner.
Ma X; Hu YW; Zhao ZL; Zheng L; Qiu YR; Huang JL; Wu XJ; Mao XR; Yang J; Zhao JY; Li SF; Gu MN; Wang Q
Arch Biochem Biophys; 2013 May; 533(1-2):1-10. PubMed ID: 23500137
[TBL] [Abstract][Full Text] [Related]
12. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlbäck B; Nielsen LB
J Biol Chem; 2008 Jan; 283(4):1839-47. PubMed ID: 18006500
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
14. TGF-β Down-regulates Apolipoprotein M Expression through the TAK-1-JNK-c-Jun Pathway in HepG2 Cells.
Ren K; Mo ZC; Liu X; Tang ZL; Jiang Y; Peng XS; Zhang QH; Shi JF; Yi GH
Lipids; 2017 Feb; 52(2):109-117. PubMed ID: 28039587
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Xu N; Ahrén B; Jiang J; Nilsson-Ehle P
Biochim Biophys Acta; 2006 Feb; 1761(2):256-60. PubMed ID: 16542871
[TBL] [Abstract][Full Text] [Related]
16. Foxa2 may modulate hepatic apoptosis through the cIAP1 pathway.
Wang K; Brems JJ; Gamelli RL; Holterman AX
Cell Signal; 2013 Apr; 25(4):867-74. PubMed ID: 23275033
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein M.
Ren K; Tang ZL; Jiang Y; Tan YM; Yi GH
Clin Chim Acta; 2015 Jun; 446():21-9. PubMed ID: 25858547
[TBL] [Abstract][Full Text] [Related]
18. Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.
Yi-zhou Y; Bing C; Ming-qiu L; Wei W; Ru-xing W; Jun R; Liu-yan W; Zhao-hui J; Yong J; Guo qing J; Jian Z
Lipids Health Dis; 2012 Dec; 11():168. PubMed ID: 23216709
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
Wolfrum C; Poy MN; Stoffel M
Nat Med; 2005 Apr; 11(4):418-22. PubMed ID: 15793583
[TBL] [Abstract][Full Text] [Related]
20. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.
Wei J; Shi Y; Zhang X; Feng Y; Luo G; Zhang J; Mu Q; Tang Y; Yu Y; Pan L; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2011 Dec; 1811(12):1146-51. PubMed ID: 21816233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
